Reply to comment on: Optical coherence tomography angiography in central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: A comparative study

Eur J Ophthalmol. 2024 May;34(3):NP132-NP133. doi: 10.1177/11206721231199124. Epub 2023 Oct 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Administration, Oral
  • Central Serous Chorioretinopathy* / diagnosis
  • Central Serous Chorioretinopathy* / drug therapy
  • Eplerenone* / administration & dosage
  • Eplerenone* / therapeutic use
  • Fluorescein Angiography* / methods
  • Humans
  • Mineralocorticoid Receptor Antagonists* / administration & dosage
  • Mineralocorticoid Receptor Antagonists* / therapeutic use
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Spironolactone* / administration & dosage
  • Tomography, Optical Coherence*
  • Visual Acuity

Substances

  • Eplerenone
  • Mineralocorticoid Receptor Antagonists
  • Spironolactone
  • Photosensitizing Agents